Swee Yeok Chu
Directeur/Membre du Conseil chez PEGASUS ASIA
Profil
Swee Yeok Chu is currently the President, CEO & Executive Director at EDBI Pte Ltd.
She is also a Director at Biomedical Sciences Investment Fund Pte Ltd.
and an Independent Non-Executive Director at Singapore Post Ltd.
Additionally, she holds positions as a Non-Executive Director at Singapore Suzhou Township Development Pte Ltd., Director at A-Bio Pharma Pte Ltd., Non-Executive Director at National Healthcare Group Pte Ltd., Director at Alexandra Health Endowment Fund, Independent Director at Pegasus Asia, Director at Anext Bank Pte Ltd., Senior Advisor at EDB Investments Pte Ltd., and Senior Advisor at Bio*One Capital Pte Ltd.
In the past, Ms. Chu has served as a Director at Silecs International Pte Ltd., MerLion Pharmaceuticals Pte Ltd., S*BIO Pte Ltd., ES Cell International Pte Ltd., and Alexandra Health System Pte Ltd.
She completed her undergraduate degree at the National University of Singapore.
Postes actifs de Swee Yeok Chu
| Sociétés | Poste | Début |
|---|---|---|
| SINGAPORE POST LIMITED | Directeur/Membre du Conseil | 01/09/2018 |
| PEGASUS ASIA | Directeur/Membre du Conseil | 05/01/2022 |
EDBI Pte Ltd.
 EDBI Pte Ltd. Investment ManagersFinance EDBI Pte Ltd. provides investment services. It offers investments in biomedical sciences, information and communication technology, smart and sustainable technology. The company was founded in 1991 and is headquartered in Singapore. | Directeur Général | 01/01/2008 |
Biomedical Sciences Investment Fund Pte Ltd.
 Biomedical Sciences Investment Fund Pte Ltd. Investment ManagersFinance Biomedical Sciences Investment Fund Pte Ltd seeks investment opportunities in Singapore, Europe, Asia and the US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals and medical technology companies. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | - |
National Healthcare Group Pte Ltd.
 National Healthcare Group Pte Ltd. Medical/Nursing ServicesHealth Services National Healthcare Group Pte Ltd. provides public healthcare services. It offers care through an integrated network and collaborate with hospitals, specialty centres, polyclinics, patients, caregivers, partners, volunteers and the community. The company is headquartered in Singapore. | Directeur/Membre du Conseil | - |
| Alexandra Health Endowment Fund | Directeur/Membre du Conseil | - |
Singapore Suzhou Township Development Pte Ltd.
 Singapore Suzhou Township Development Pte Ltd. Real Estate DevelopmentFinance Singapore Suzhou Township Development Pte Ltd. provides real estates services. It also engages in harbor and related offshore structure construction. The company is headquartered in Singapore. | Directeur/Membre du Conseil | - |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | President | 01/01/2008 |
A-Bio Pharma Pte Ltd.
 A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Swee Yeok Chu
| Sociétés | Poste | Fin |
|---|---|---|
| ░░ ░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Swee Yeok Chu
| National University of Singapore | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SINGAPORE POST LIMITED | Transportation |
| PEGASUS ASIA | Finance |
| Entreprise privées | 14 |
|---|---|
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Health Technology |
Bio*One Capital Pte Ltd.
 Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Health Technology |
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Commercial Services |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Finance |
Silecs International Pte Ltd.
 Silecs International Pte Ltd. Electronic Production EquipmentElectronic Technology Silecs International Pte Ltd. manufactures and markets siloxane polymers for microelectronics sector. Its products include semiconductor mask manufacturing, fabrication and packaging. The compnay was founded by Juha Rantala and Kokko Jaakko in 2000 and is headquartered in Singapore. | Electronic Technology |
Singapore Suzhou Township Development Pte Ltd.
Singapore Suzhou Township Development Pte Ltd. Real Estate DevelopmentFinance Singapore Suzhou Township Development Pte Ltd. provides real estates services. It also engages in harbor and related offshore structure construction. The company is headquartered in Singapore. | Finance |
| Alexandra Health Endowment Fund | |
EDBI Pte Ltd.
EDBI Pte Ltd. Investment ManagersFinance EDBI Pte Ltd. provides investment services. It offers investments in biomedical sciences, information and communication technology, smart and sustainable technology. The company was founded in 1991 and is headquartered in Singapore. | Finance |
National Healthcare Group Pte Ltd.
National Healthcare Group Pte Ltd. Medical/Nursing ServicesHealth Services National Healthcare Group Pte Ltd. provides public healthcare services. It offers care through an integrated network and collaborate with hospitals, specialty centres, polyclinics, patients, caregivers, partners, volunteers and the community. The company is headquartered in Singapore. | Health Services |
Biomedical Sciences Investment Fund Pte Ltd.
Biomedical Sciences Investment Fund Pte Ltd. Investment ManagersFinance Biomedical Sciences Investment Fund Pte Ltd seeks investment opportunities in Singapore, Europe, Asia and the US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals and medical technology companies. It provides financing for early stage capital requirements. | Finance |
Alexandra Health System Pte Ltd.
 Alexandra Health System Pte Ltd. Hospital/Nursing ManagementHealth Services Alexandra Health System Pte Ltd. provides multi-disciplinary and holistic care services for patients. | Health Services |
Anext Bank Pte Ltd.
 Anext Bank Pte Ltd. Regional BanksFinance Anext Bank Pte Ltd is a digital wholesale bank based in Singapore, SG. Anext Bank is dedicated to accelerating fintech development and financial inclusion in Singapore and the region through continuous technology-driven innovation. The Singaporean company focuses on providing innovative and secure digital financial services to local and regional micro, small and medium enterprises (SMEs) to aid their growth and expansion. | Finance |
